Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized, multicenter, open-label clinical trial of Olmesartan/Amlodipine Administered in the Morning or at Night on Nocturnal Blood Pressure Reduction in Chinese Patients with Mild-Moderate Essential Hypertension (Oman Trial)

Next Previous
Search
Trial Profile

A randomized, multicenter, open-label clinical trial of Olmesartan/Amlodipine Administered in the Morning or at Night on Nocturnal Blood Pressure Reduction in Chinese Patients with Mild-Moderate Essential Hypertension (Oman Trial)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Jul 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Olmesartan medoxomil/amlodipine (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms Oman Trial

    • Most Recent Events

    • 03 Jun 2024 Results comparing the effects of morning and bedtime antihypertensive administration on the nocturnal blood pressure (BP) reduction and the circadian rhythm of hypertensives, presented at the 33rd European meeting on hypertension and cardiovascular protection.
    • 28 May 2024 New trial record
    • 08 Apr 2024 Results (n= 382) assessing The Effects of Olmesartan/Amlodipine Administered in the Morning or at Night on Nocturnal Blood Pressure Reduction in Chinese Patients with Mild-Moderate Essential Hypertension presented at the 73rd Annual Scientific Session of the American College of Cardiology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top